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Background: Netrin-1 has been reported to promote retinal neovascularization in oxygen-induced retinopathy
(OIR). However, netrin-1 receptors, which may mediate netrin-1 action during retinal neovascularization, have not
been characterized. In this study, we investigated netrin-1 receptor subtype expression and associated changes in
the retinas of mice with OIR.
Methods: C57BL/6J mice were exposed to 75±2% oxygen for 5 days and then returned to normal air to induce
retinal neovascularization. Reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot were used to
examine the expression of netrin-1 receptor subtypes in the mouse retinas. Double staining of netrin-1 receptor
subtypes and isolectin B4 was used to determine the location of the netrin-1 receptor subtypes in the retinas.
Inhibition of retinal neovascularization was achieved by UNC5B shRNA plasmid intravitreal injection. Retinal
neovascularization was examined by fluorescein angiography and quantification of preretinal neovascular nuclei in
retinal sections.
Results: RT-PCR results showed that, except for UNC5A, netrin-1 receptor subtypes UNC5B, UNC5C, UNC5D, DCC,
neogenin, and A2b were all expressed in the retinas of OIR mice 17 days after birth. Western blots showed
that only UNC5B expression was significantly increased on that day, and immunofluorescence results showed that only
UNC5B and neogenin were expressed in retinal vessels. Treatment of OIR mice with the UNC5B shRNA plasmid
dramatically reduced neovascular tufts and neovascular outgrowth into the inner limiting membrane.
Conclusions: UNC5B may promote retinal neovascularization in OIR mice.
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Netrin-1 has been reported to stimulate proliferation
and migration of endothelial cells in vitro, and promote
developmental and pathological angiogenesis in vivo
[1,2]. To investigate the role of netrin-1 in retinal angio-
genesis, we characterized the expression of netrin-1 in
the retinas of mice with oxygen-induced retinopathy
(OIR) [3], and injected netrin-1 shRNA into the vitreous
cavity of OIR mice [4]. We showed that netrin-1 expres-
sion was simultaneously elevated with an increase of ret-
inal neovascularization. Intravitreal injection of netrin-1
shRNA effectively inhibited retinal neovascularization,
indicating that netrin-1 may promote retinal angiogen-
esis in OIR mice.* Correspondence: xiaxiaobo2013@163.com
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unless otherwise stated.In mammals, receptors of netrin-1 include the DCC
family (deleted in colorectal cancers) and the UNC5 ho-
mologs. Together, the receptors include DCC, neogenin,
UNC5A, UNC5B, UNC5C, and UNC5D. A2b was also re-
ported to be a netrin-1 receptor [5]. As an axonal guidance
cue, netrin-1 attracts or repels axonal growth, depending
on which receptor subtype it recognizes. DCC mediated
chemoattraction [6], while repulsion required a UNC5
homolog, acting alone or together with DCC family re-
ceptors [7,8]. However, whether netrin-1 receptors are
expressed in the retinas of OIR mice, and which subtypes
are involved in retinal neovascularization during this ex-
pression, are presently unknown. The current study was
designed to characterize these receptors and subtypes. We
have developed an OIR model in mice, and have charac-
terized the expression of the netrin-1 receptors UNC5A-D,
DCC, neogenin, and A2b in the retinas of normal and OIRThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lated with retinal angiogenesis in OIR mice, and the ex-
pressions of UNC5B and neogenin were located in new
OIR vessels. Based upon these observations, UNC5B and/
or neogenin may be involved in retinal neovascularization.
We then injected a UNC5B shRNA plasmid into the vitre-
ous cavity of OIR mice, and observed that the inhibition of
retinal neovascularization, consistent with UNC5B, may
promote retinal neovascularization in these mice.
Methods
Animal model
C57BL/6 J mice were available from the animal center of
Central South University, were used in the present study.
IR was produced as described by Smith et al. [9]. Seven-
day-old mice were exposed to 75 ± 5% oxygen for 5 days,
together with their nursing mothers. At postnatal day 12
(P12), the animals were returned to room air (21% oxygen).
The mice were then exposed to 12 hours of cyclical broad
spectrum light. The room temperature was maintained
at 23°C − 28°C. For biochemical studies, mice were sacri-
ficed by neck dislocation, and for histological analyses,
mice were sacrificed by hyper-anesthesia. All experimental
procedures used in the present study were approved by
Ethics Committee of Xiangya School of Medicine, in ac-
cordance with the NIH guidelines for use and care of la-
boratory animals.
Assessment of retinal vascularization
Angiography with high-molecular-weight fluorescein-dextran
was performed on P17. Normal and OIR mice were anes-
thetized using intraperitoneal injection of pentobarbital
sodium, and perfused through the left ventricle with
phosphate-buffered saline (PBS) containing 1 mL 50 g/L
fluorescein-labeled high-molecular-weight (2 million) dex-
tran (Sigma-Aldrich, St. Louis, MO, USA). Subsequently,
the eyes were enucleated and fixed in 40 g/L paraformal-
dehyde for 10 minutes. The retinas were dissected and
placed in 40 g/L paraformaldehyde for 10 minutes, then
flat-mounted using a 1:1 solution of glycerol and PBS.
Histological analysis of neovascularization
On P17, the eyes of normal and OIR mice were enucleated,
fixed with 40 g/L paraformaldehyde in PBS overnight at 4°C,
then embedded in paraffin. Serial cross sections (5 μm) of
the whole eye were stained with hematoxylin and eosin to
visualize the cell nuclei. Ten non-serial sections, except
sections containing the optic nerve, were analyzed per eye.
The nuclei of new vessels extending from the retina to the
vitreous were counted in 60 sections in each group.
Immunofluorescent staining of netrin-1 receptor subtypes
Eyeballs were removed following transcardiac perfusion
with 4% paraformaldehyde in PBS at certain survivaltime points, then postfixed in perfusion solution over-
night, followed by cryoprotection in 30% sucrose. Sagittal
frozen sections of retina were cut to a thickness of 12 μm,
and mounted on glass slides. The retinal sections were
covered with 5% BSA for 2 hours at room temperature to
reduce nonspecific background staining. To identify the
expression of receptor subtypes in vascular endothelial
cells, double staining to detect UNC5B-D, DCC, and neo-
genin with isolectin B4 (an endothelial cell marker) was
performed. The retinal sections were incubated with the
primary antibodies, which were diluted in PBS containing
3% bovine serum albumin (BSA), overnight at 4°C. The
primary antibodies included goat polyclonal anti-UNC5B
(AF1006 1:50, R&D Systems, MN, USA), goat polyclonal
anti-UNC5C (SC-54441 1:100, Santa Cruz Biotechnology,
CA, USA), rabbit polyclonal anti-UNC5D (SC-135262
1:100, Santa Cruz Biotechnology), rabbit polyclonal anti-
neogenin (SC-15337 1:100, Santa Cruz Biotechnology),
rabbit polyclonal anti-DCC (SC-35184 1:100, Santa Cruz
Biotechnology), rabbit polyclonal anti-A2b (SC-28996
1:100, Santa Cruz Biotechnology), and mouse anti-GAPDH
(Mab-2005079 1:8000, ProMab, CA, USA).
The sections were rinsed with PBS three times and incu-
bated with 1:300 Cy3-conjugated secondary (Sigma-Aldrich)
and 1:400 Alexa 488-conjugated antibody (Invitrogen,
Grand Island, NY, USA) for 2 hours at room temperature.
Control sections were prepared by incubating with the
BSA mixture without the primary antibody. Sections were
counterstained with Hoechst 33342 (1:50, Sigma-Aldrich),
washed, and mounted with anti-fading medium, before
microscopy examination. Digital images were obtained
using fluorescence microscopy (BH-40; Olympus, Tokyo,
Japan). The immunofluorescence staining procedure was
repeated three times.
RT-PCR analysis of netrin-1 receptor mRNA expression
Expressions of UNC5A-D, DCC, and neogenin mRNA
were determined using reverse transcriptase polymerase
chain reaction (RT-PCR). We used brain tissue as a posi-
tive control. Retinas were lysed in TRIzol, and RNA was
extracted and purified without any contaminating gen-
omic DNA, according to the manufacturer’s instructions
(Invitrogen). The first strand of cDNA was transcribed
from 2 μg total RNA using oligo(dT) (Invitrogen). The
first strand with cDNA not added was used as a negative
control and generated using Moloney murine leukemia
virus transcriptase (Invitrogen). PCR was performed using
the following primer pairs:
A2b, 5′-CTACTTTCTGGTATCCCTGG-3′ and 5′-
CTCGGTTCCTGTAGGCATAG-3′;
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Amplification was performed with a cycle (94°C/
5 minutes), (94°C/45 seconds, Tm/45 seconds, 72°C/
45 seconds) × 32 cycles, 72°C/10 minutes. The Tm of each
receptor was UNC5A, 56°C; UNC5B, 56°C; UNC5C, 5°C;
UNC5D, 52°C; A2b, 60°C; DCC, 60°C; and neogenin, 52°C.
Western blot analysis of the netrin-1 receptor protein
For biochemical studies, the eyeballs were removed after
neck dislocation on P12, P17, and P21, and the animals
with weight >6 g were used. The retinas were dissected
and placed in cold PBS on ice, carefully soaked with a
piece of filter paper, and collected in 1.5-ml test tubes
and weighed. They were dissected and lysed in radio-
immunoprecipitation assay (RIPA) lysis buffer (Pierce,
Rockford, IL, USA). Protein concentrations were de-
termined with a protein assay reagent (Pierce, Rockford,
IL, USA), using the bicinchoninic acid assay method.
For each sample, 100 μg protein was fractionated using
10% sodium dodecyl sulfate polyacrylamide gel electro-
phoresis, and transferred onto polyvinylidene mem-
branes (Pierce). The membranes were incubated with
anti-UNC5B (1:100), anti-UNC5C (1:100), anti-UNC5D
(1:100), anti-DCC (1:50), anti-A2b(1:100), or anti-neogenin
(1:100) for 2 hours at room temperature, then incu-
bated with a specific secondary antibody (horseradish
peroxidase-conjugated anti-immunoglobulin G). Bind-
ing was detected using an enhanced chemiluminescence
(ECL) method.
Working solutions for the ECL method were prepared
according to the manufacturer’s instructions, and added
to the membranes for 1 minute. The membranes were
removed from the solutions and placed in plastic sheet
protectors. Each membrane was exposed to CL-Xposure
film (Pierce) for 90 seconds. The experiments were re-
peated three times. Band intensities were quantified with
BandScan software Version 4.5 (Glyko Software, Novato,
CA, USA). Levels of glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH) production were used for
standardization. Results are expressed as the ratio of
specific protein to GAPDH production.
Intravitreal injection for UNC5B shRNA infection
On P12, ten mice were anesthetized by intraperitoneal
injection of 10% chloral hydrate (30 mg/kg body weight).Intravitreal injections were performed using a 32-gauge
Hamilton needle and syringe. Among the 10 mice, one
eye was intravitreally injected with 1 μl of the UNC5B
shRNA plasmid (Santa Cruz Biotechnology, sc-61847-
SH), and the other eye, as the negative control, received
an intravitreal injection with 1 μl of the control shRNA
plasmid-A (Santa Cruz Biotechnology, sc-108060). To
assess the angiostatic effect of UNC5B shRNA on retinal
neovascularization, fluorescein angiography and quantifi-
cation of preretinal neovascular nuclei in retinal sections
were performed on P17.
Statistical analysis
All data were expressed as the mean ± SD. Student’s t-
test was used to compare groups. Significance was set at
p < 0.05.
Results
Analysis of retinal neovascularization
Fluorescence angiography was used to visualize the ret-
inal vasculature of normal and OIR mice. Retinas from
normal mice had both superficial and deep vascular
layers, which extended from the optic nerve to the per-
iphery. Vessels in the superficial retinal layer formed a
fine radial branching pattern. In deep retinal layers, the
vessels formed a polygonal reticular pattern (Figure 1a).
Retinas from OIR mice were characterized by central
nonperfused areas and neovascular tufts (Figure 1b). Ser-
ial paraffin cross sections were used to count the num-
ber of neovascular nuclei on the vitreal side of the
internal limiting membrane. In OIR mouse retinas, many
vascular cell nuclei extended beyond the internal limit-
ing membrane (Figure 1d,e), and the average number of
neovascular nuclei per section was 50.70 ± 4.56, while
there were very few neovascular nuclei in the normoxic
control mice (Figure 1c,e).
RT-PCR results
Brain tissue was used as a positive control, and no RNA
was used as a negative control. Except UNC5A, we de-
termined that netrin-1 receptors, UNC5B, UNC5C,
UNC5D, neogenin, A2b, and DCC were all expressed in
the retinas of OIR mice on P17 (Figure 2).
Western blots
Compared with normal mice, expression of all the re-
ceptors showed no differences in the OIR mice on P12
(Figure 3, p > 0.05). The expression of UNC5B in the ret-
ina of OIR mice was significantly upregulated, compared
with normal mice, on P17 and P21 (Figure 3, p < 0.05),
while the expression of UNC5C, UNC5D, neogenin, A2b,
and DCC showed no difference between normal and OIR
mice (Figure 3, all p > 0.05). In normal mice, DCC expres-
sion was greater on P12 than on P17 and P21 (Figure 3,
Figure 1 Assessment of retinal vascularization. (a, b) Angiographic analysis by fluorescein-dextran. (c, d) Histological demonstration of retinal
neovascularization. (a, c) Normal mice. (e) Quantification of retinal neovascularization. (b, d) Oxygen-induced retinopathy (OIR) mice. (a) Normal
mice, retinal vessels form a polygonal reticular pattern. (b) OIR mice, neovascular tufts appear as hyperfluorescence at the junction between the
perfused and nonperfused areas (indicated by red arrows). The nonperfused areas are marked with an asterisk. (c) Normal mice, no neovascular
cell nuclei extend beyond the internal limiting membrane. (d) OIR mice, many neovascular cell nuclei protrude into the vitreous cavity
(indicated by arrows). GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer
nuclear layer. Bar = 50 μm.
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P17 and P21 (Figure 3, p > 0.05), while neogenin expres-
sion increased (Figure 3, p < 0.05) from P12 to P21. Last,
the expressions of UNC5B, UNC5C, UNC5D, and A2b
showed no differences on P12, P17, and P21 in normal
mice (Figure 3, p > 0.05).
Staining of netrin-1 receptors in retina
Confocal microscopy of double immunostaining showed
that UNC5B, UNC5C, UNC5D, neogenin, A2b, and DCC
were expressed in the ganglion cell layer, inner plexi-
form layer, and outer plexiform layer of retinas. There
was no significant difference among the six receptor
subtypes (Figures 4,5,6,7,8,9, green). However, isolec-
tin B4 staining (an endothelial cell marker) was greater in
OIR than in normal mice (Figures 4,5,6,7,8,9, red),
and only UNC5B and neogenin were colocalized with
isolectin B4 in OIR mice (Figures 4 and 8, yellow, in-
dicated by arrows).Suppression of UNC5B expression by UNC5B shRNA in
OIR mice
The effects of targeting UNC5B with RNAi on UNC5B ex-
pression were investigated by infection of UNC5B shRNA
or scrambled shRNA control in retinas of OIR mice. Com-
pared with scrambled shRNA injection, intravitreal injec-
tion of UNC5B shRNA on P12 resulted in downregulation
of UNC5B expression in the retinas of OIR mice on
P17 (Figure 10).
Suppression of retinal neovascularization by the UNC5B
shRNA plasmid
To determine the angiostatic effect of UNC5B shRNA plas-
mid on ischemia-induced retinal neovascularization, fluor-
escein angiography was performed on OIR mice on P17.
Retinas of OIR mice transfected with scrambled shRNA
hadmultiple neovascular tufts (hyperfluorescence, Figure 11a).
In contrast, fewer neovascular complexes were observed
in the retinas of OIR mice transfected with the UNC5B
Figure 3 Expression of UNC5B-D, DCC, neogenin, and A2b in retinas of normal and OIR mice on P12, P17, and P21. (a) Expression of
UNC5B-D, DCC, neogenin, and A2b in normal and OIR mice. (b) Relative grayscale of UNC5B-D, DCC, neogenin, A2b, and GAPDH in normal and
OIR groups. The UNC5B level of the OIR group is increased significantly compared with the normal group on P17 and P21 (p < 0.05), while the
expressions of UNC5C, UNC5D, neogenin, A2b, and DCC show no significant differences between the normal and OIR mice (p > 0.05). In normal
mice, DCC expression is greater on P12 than P17 and P21 (p < 0.05), and neogenin expression increases (p < 0.05) from P12 to P21.
Figure 2 RT-PCR analysis of netrin-1 receptor mRNA in retinas of OIR mice. The expressions of UNC5B, UNC5C, UNC5D, neogenin, A2b, and
DCC are all detected in retinas of OIR mice, while UNC5A is not detected.
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Figure 4 Double immunostaining of UNC5B with isolectin B4. UNC5B is expressed in the ganglion cell layer, inner plexiform layer, and outer
plexiform layer, and the expression of UNC5B is elevated in OIR mice compared with normal mice. (a, e; green). Endothelial cells increase more
in OIR mice than in normal mice (b, f; red). Hoechst staining in normal and OIR mice (c, g, blue). UNC5B colocalizes with isolectin B4 in OIR mice
(d, h; yellow, indicated by arrows). GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL,
outer nuclear layer. Bar = 50 μm.
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hibitory effects of UNC5B shRNA on angiogenesis, retinal
neovascularization was assessed histologically by counting
the neovascular nuclei protruding into the vitreous cavity
(Figure 11c,d). The average number of neovascular nuclei
extending beyond the internal limiting membrane per
section was 47.32 ± 4.05 in OIR mice transfected with
UNC5B shRNA and 25.76 ± 3.68 in OIR mice injected
with scrambled shRNA, thus approximately represent-
ing a 50% reduction in retinal neovascularization.
Discussion
In OIR mice, retinal neovascularization formed after P14
and reached a maximum at P17 and P21 [9], so we de-
tected netrin-1 receptor expression on P12 (neovasculari-
zation not formed yet), P17, and P21 (neovascularization
peaked). Compared with normal mice, the expression of
UNC5B did not show statistical significance in the OIR
mice on P12, but increased significantly on P17 and P21.
Our results showed a positive correlation between UNC5B
overexpression and retinal neovascularization. For theFigure 5 Double immunostaining of UNC5C with isolectin B4. UNC5C
outer plexiform layer in normal and OIR mice (a, e, green). There are more
staining in normal and OIR mice (c, g, blue). UNC5C did not colocalize with
plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, ouother receptors, there were no significant differences be-
tween the normal and OIR mice on P12, P17 and P21.
Our immunohistochemistry results showed that UNC5B,
UNC5C, UNC5D, DCC, A2b, and neogenin were all
expressed in the ganglion cell layer, inner plexiform layer,
and outer plexiform layer, but only UNC5B and neogenin
were expressed in the retinal vessels of OIR mice. Regard-
ing the seven netrin-1 receptors, our study showed that
UNC5B and/or neogenin may have been implicated in ret-
inal neovascularization.
Among the netrin-1 receptors, UNC5B appeared to be
the best receptor candidate to mediate the angiogenic ef-
fects of netrin-1. UNC5B was expressed in developing
blood vessels in murine embryos, and controlled morpho-
genesis of the vascular system [10]. In addition to being
expressed in embryos, recent studies showed that UNC5B
was also expressed during postnatal and pathological
angiogenesis [11]. In the study by Larrive et al. [11],
UNC5B was expressed in sprouting angiogenesis induced
by OIR, matrigel, or tumor implantation, suggesting that
UNC5B may be required during sprouting angiogenesis.is expressed in the ganglion cell layer, inner plexiform layer, and
endothelial cells in OIR mice than in normal mice (b, f, red). Hoechst
isolectin B4 in OIR mice (d,h). GCL, ganglion cell layer; IPL, inner
ter nuclear layer. Bar = 50 μm.
Figure 6 Double immunostaining of UNC5D with isolectin B4. UNC5D is expressed in the ganglion cell layer, inner plexiform layer, and outer
plexiform layer in normal and OIR mice. (a, e, green). There are more endothelial cells in OIR mice than in normal mice (b, f, red). Hoechst
staining in normal and OIR mice (c, g, blue). UNC5D does not colocalize with isolectin B4 in OIR mice (d, h). GCL, ganglion cell layer; IPL, inner
plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer. Bar = 50 μm.
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B4 in cross sections showed that UNC5B was expressed
in the endothelial cells of newly formed retinal vessels
in OIR mice. This result confirmed the conclusions of
Larrive et al. [11], and indicated that UNC5B may be
required for retinal neovascularization. Furthermore, in
the current study, we showed that expression of UNC5B
was significantly elevated on P17, compared with normal
age-matched mice. At the same time, new vessels were
formed in OIR mice, so there was a significant positive
correlation between UNC5B overexpression and retinal
neovascular formation. Because the expression of UNC5B
was localized to the sprouting vessels and was significantly
elevated during the active angiogenic period of the OIR
mice, we postulated a role of UNC5B in hypoxia-driven
neovascularization. In our previous studies [3,11], we de-
tected the overexpression of netrin-1 in OIR mice on P17,
so there was also a positive correlation between netrin-1
overexpression and UNC5B overexpression in OIR mice
on P17, suggesting that UNC5B mediated netrin-1 action
during retinal neovascularization.Figure 7 Double immunostaining of DCC with isolectin B4. DCC is exp
plexiform layer in normal and OIR mice. (a, e, green). There are more endo
staining in normal and OIR mice (c, g, blue). DCC does not colocalize with
plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, ouHowever, the possible role of UNC5B in angiogenesis
has been controversial. Some studies [10,11] suggested
that UNC5B was a repulsive netrin-1 receptor in endo-
thelial cells, controlling morphogenesis of the vascular
system. Activation of UNC5B could therefore inhibit de-
velopmental and pathological angiogenesis. However,
others [12,13] reported that UNC5B was a proangiogenic
factor for vessels in vivo and in vitro. Navankasattusas
et al. [12] observed that umbilical arteries isolated from
UNC5B-deficient embryos were unable to support vessel
outgrowth in vitro, and deletion of UNC5B in endothe-
lial cells in mice led to reduction of placental arterioles.
Epting et al. [13] reported that netrin-1 and its receptor,
UNC5B, were upstream regulators of ELMO1/DOCK180
in endothelial cells, leading to Rac1 activation in vitro,
which has been reported to be necessary for vascular de-
velopment [14]. To reconcile this controversy, Castets
et al. [15] reported that unbound UNC5B acted in a proa-
poptotic manner in endothelial cells, while netrin-1 bound
to UNC5B acted as a survival signal for endothelial cells,
provoking a proangiogenic response. However, whetherressed in the ganglion cell layer, inner plexiform layer, and outer
thelial cells in OIR mice than in normal mice (b, f, red). Hoechst
isolectin B4 in OIR mice (d, h). GCL, ganglion cell layer; IPL, inner
ter nuclear layer. Bar = 50 μm.
Figure 8 Double immunostaining of neogenin with isolectin B4. Neogenin is expressed in the ganglion cell layer, inner plexiform layer, and
outer plexiform layer in normal and OIR mice (a, e, green). There are more endothelial cells in OIR mice than in normal mice (b, f, red). Hoechst
staining in normal and OIR mice (c, g, blue). Neogenin colocalizes with isolectin B4 in OIR mice (d, h; yellow, indicated by arrows). GCL, ganglion
cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL = outer nuclear layer. Bar = 50 μm.
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tion of OIR mice was still unknown. To further investi-
gate the role of UNC5B in retinal neovascularization, we
observed the effects of inhibition of retinal angiogenesis
by RNA interference (RNAi) of UNC5B in the OIR
mouse model. As shown in the present study, UNC5B
expression decreased dramatically following UNC5B
shRNA infection, and retinal neovascularization was
clearly reduced by UNC5B shRNA infection. Together,
these results showed that UNC5B functioned as a
proangiogenic growth factor in the pathological neo-
vascularization of OIR mice. Therefore, UNC5B could
be a novel target for the therapy of diabetic retinopathy,
retinopathy of prematurity, and other ocular neovascular
diseases.
Neogenin is another receptor subtype of netrin-1 impli-
cated in angiogenesis. A previous study [1] reported that
neogenin was expressed in vascular smooth muscle cells
(VSMCs), showing that it was responsible for cell migra-
tion and proliferation of VSMCs mediated by netrin-1.
Lejmi et al. [16] reported that neogenin was upregulatedFigure 9 Double immunostaining of A2b with isolectin B4. A2b is exp
plexiform layer in normal and OIR mice (a, e, green). There are more endot
staining in normal and OIR mice (c, g, blue). A2b does not colocalize with
plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, ouin vascular endothelial growth factor-stimulated endo-
thelial cells, choroidal neovessels, and tumor angio-
genesis, while silencing of either neogenin or UNC5B
abolished netrin-4′s inhibitory effect on endothelial
cell migration, choroidal neovascularization, and tumor
angiogenesis.
Consistent with these studies, we also observed that
neogenin was expressed in the newly formed retinal ves-
sels. This result may indicate a role of neogenin in ret-
inal neovascularization, although neogenin expression
was not elevated during the active angiogenic period of
OIR mice. However, in addition to being a receptor
for netrin-1, neogenin is also a receptor for the repul-
sive guidance molecule (RGM) families. While netrin-
1–neogenin interactions resulted in a chemoattractive
axon guidance response, the interaction between neo-
genin and RGM induced a chemorepulsive response [17].
Thus, further studies are needed to determine whether
neogenin binds to netrin-1 or RGM in retinas of OIR
mice, and whether neogenin participates in retinal
neovascularization.ressed in the ganglion cell layer, inner plexiform layer, and outer
helial cells in OIR mice than in normal mice (b, f, red). Hoechst
isolectin B4 in OIR mice (d, h). GCL, ganglion cell layer; IPL, inner
ter nuclear layer. Bar = 50 μm.
Figure 10 Western blot analysis of the effects of UNC5B shRNA on UNC5B expression in murine retinas. Representative western blot
(a) and relative expression of UNC5B in murine retinas (b). UNC5B expression is significantly decreased in the retinas of OIR mice transfected with
UNC5B shRNA, compared with scrambled shRNA on P17 (p < 0.01).
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http://www.biomedcentral.com/1471-2415/14/102In the present study, we did not detect UNC5A in
the retinas of OIR mice on P17. In addition, although
we observed the expression of UNC5C, UNC5D, DCC,
and A2b in the retinas of OIR mice, the expressions
of these receptors were not significantly differentFigure 11 Inhibition of ischemia-induced retinal neovascularization
shRNA. (b, d) Retinas transfected with UNC5B shRNA. (e) Quantification
fluorescein-dextran, the numbers of neovascular tufts (marked by white
(c,d) Histological demonstration of retinal neovascularization, UNC5B sh
preretinal neovascularization. GCL, ganglion cell layer; IPL, inner plexifor
outer nuclear layer. Bar = 50 μm.between the OIR mice and normal mice. They were
also not detected in newly formed vessels by im-
munofluorescent staining, suggesting that these recep-
tors may not be involved in retinal neovascularization
in OIR mice.by UNC5B shRNA. (a, c) Retinas transfected with scrambled
of retinal neovascularization. (a, b) Angiographic analysis by
arrows) are reduced in the retinas transfected with UNC5B shRNA.
RNA infection results in approximately a 50% reduction of
m layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL,
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UNC5B may promote retinal neovascularization in OIR
mice, and may be a novel target for the therapy of ocular
neovascular diseases.
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